A M Triggle

Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines.

J Hampshire, P Hebborn, A M Triggle, 1965, Journal of medicinal chemistry.

Potential folic acid antagonists. 3. The antitumor and folate reductase inhibitory properties of some irreversibly acting 6-N-substituted 2,4,6-triamino-5-(4-carbethoxyphenylazo)pyrimidines.

J Hampshire, P Hebborn, A M Triggle, 1968, Journal of medicinal chemistry.

Chemical and pharmacological approaches to the definition and quantitation of calcium channels.

A M Triggle, D J Triggle, R A Janis, 1983, Cold Spring Harbor symposia on quantitative biology.

Calcium channels in smooth muscle. Properties and regulation.

A M Triggle, D J Triggle, A Joslyn, 1989, Annals of the New York Academy of Sciences.

Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.

A M Triggle, D J Triggle, A. M. Triggle, 1980, Journal of medicinal chemistry.

6-substituted 2,4-diamino-5-(4-carbethoxyphenylazo)pyrimidines as potential precursors of tetrahydropteridine antimetabolites.

J Hampshire, P Hebborn, A M Triggle, 1966, Journal of medicinal chemistry.

1,4-Dihydropyridine antagonist activities at the calcium channel: a quantitative structure-activity relationship approach.

A M Triggle, D J Triggle, A J Solo, 1988, Journal of medicinal chemistry.